Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).

Straus, D J

Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV). [electronic resource] - Cancer chemotherapy and pharmacology 1983 - 80-5 p. digital

Publication Type: Journal Article

0344-5704

10.1007/BF00254250 doi


Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bleomycin--administration & dosage
Doxorubicin--administration & dosage
Female
Hodgkin Disease--drug therapy
Humans
Lomustine--administration & dosage
Male
Mechlorethamine--administration & dosage
Melphalan--administration & dosage
Middle Aged
Prednisone--administration & dosage
Procarbazine--administration & dosage
Vinblastine--administration & dosage
Vincristine--administration & dosage
Vindesine